Tarsus Pharmaceuticals (TARS) Short Interest Ratio & Short Volume $49.72 -0.28 (-0.56%) Closing price 04/28/2025 04:00 PM EasternExtended Trading$49.74 +0.02 (+0.04%) As of 04/28/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tarsus Pharmaceuticals Short Interest DataTarsus Pharmaceuticals (TARS) has a short interest of 8.38 million shares, representing 23.89% of the float (the number of shares available for trading by the public). This marks a 9.54% increase in short interest from the previous month. The short interest ratio (days to cover) is 13.3, indicating that it would take 13.3 days of the average trading volume of 689,959 shares to cover all short positions.Current Short Interest8,380,000 sharesPrevious Short Interest7,650,000 sharesChange Vs. Previous Month+9.54%Dollar Volume Sold Short$411.63 millionShort Interest Ratio13.3 Days to CoverLast Record DateApril 15, 2025Outstanding Shares38,377,000 sharesShort Percent of Float23.89%Today's Trading Volume685,350 sharesAverage Trading Volume689,959 sharesToday's Volume Vs. Average99% Short Selling Tarsus Pharmaceuticals? Sign up to receive the latest short interest report for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTARS Short Interest Over TimeTARS Days to Cover Over TimeTARS Percentage of Float Shorted Over Time Tarsus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20258,380,000 shares $411.63 million +9.5%23.9%13.3 $49.12 3/31/20257,650,000 shares $392.98 million +3.4%21.8%11.3 $51.37 3/15/20257,400,000 shares $355.87 million +0.8%21.1%11.5 $48.09 2/28/20257,340,000 shares $326.48 million +3.7%20.9%12.1 $44.48 2/15/20257,080,000 shares $355.56 million -3.5%20.2%11.9 $50.22 1/31/20257,340,000 shares $394.60 million +4.6%N/A11.4 $53.76 1/15/20257,020,000 shares $326.85 million -4.2%N/A9.3 $46.56 12/31/20247,330,000 shares $405.86 million -2.8%N/A9.9 $55.37 12/15/20247,540,000 shares $395.85 million +5.0%N/A11.1 $52.50 11/30/20247,180,000 shares $376.59 million +0.6%N/A10.4 $52.45 Get the Latest News and Ratings for TARS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/20247,140,000 shares $320.09 million -12.5%N/A9.7 $44.83 10/31/20248,160,000 shares $363.04 million -15.7%N/A11.2 $44.49 10/15/20249,680,000 shares $360.87 million -2.7%N/A13.5 $37.28 9/30/20249,950,000 shares $327.26 million +4.9%N/A14.2 $32.89 9/15/20249,490,000 shares $315.64 million -3.1%N/A12.3 $33.26 8/31/20249,790,000 shares $265.41 million +2.6%N/A12.4 $27.11 8/15/20249,540,000 shares $257.20 million -2.3%N/A12.8 $26.96 7/31/20249,760,000 shares $237.07 million +10.8%N/A13.2 $24.29 7/15/20248,810,000 shares $246.68 million +4.1%N/A13.9 $28.00 6/30/20248,460,000 shares $229.94 million +6.3%N/A13.5 $27.18 6/15/20247,960,000 shares $246.60 million +6.4%N/A13.7 $30.98 5/31/20247,480,000 shares $246.54 million +0.1%N/A13.4 $32.96 5/15/20247,470,000 shares $287.60 million -2.5%N/A11.1 $38.50 4/30/20247,660,000 shares $240.75 million -3.0%N/A10.7 $31.43 4/15/20247,900,000 shares $276.03 million +0.6%N/A10.7 $34.94 3/31/20247,850,000 shares $285.35 million +9.0%N/A10.1 $36.35 3/15/20247,200,000 shares $227.38 million +19.4%N/A9.3 $31.58 2/29/20246,030,000 shares $230.47 million +6.5%N/A7.5 $38.22 2/15/20245,660,000 shares $178.57 million +4.2%N/A7.7 $31.55 1/31/20245,430,000 shares $147.91 million +8.2%N/A7.7 $27.24 1/15/20245,020,000 shares $110.94 million +0.4%N/A7.9 $22.10 12/31/20235,000,000 shares $101.25 million +1.8%N/A8.2 $20.25 12/15/20234,910,000 shares $93.54 million +10.3%N/A8.3 $19.05 11/30/20234,450,000 shares $73.56 million -0.2%N/A8.1 $16.53 11/15/20234,460,000 shares $79.97 million +6.2%N/A9.2 $17.93 10/31/20234,200,000 shares $59.81 million +5.0%N/A10.1 $14.24 10/15/20234,000,000 shares $51.92 million -19.4%N/A7.6 $12.98 9/30/20234,960,000 shares $88.14 million +13.0%N/A10.2 $17.77 9/15/20234,390,000 shares $70.85 million -2.7%N/A10.1 $16.14 8/31/20234,510,000 shares $78.97 million +0.7%N/A10.8 $17.51Crypto’s crashing…but we’re still profiting (Ad)Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess. The news is screaming fear. But while most traders watch their portfolios tank…my friend Joel and his team at The Crypto Code are doing the opposite. 8/15/20234,480,000 shares $76.16 million +17.9%N/A11.3 $17.00 7/31/20233,800,000 shares $83.64 million +65.9%N/A9.9 $22.01 7/15/20232,290,000 shares $40.42 million +2.2%13.0%10.7 $17.65 6/30/20232,240,000 shares $40.48 million +42.7%11.4%11 $18.07 6/15/20231,570,000 shares $29.23 million +72.6%8.0%7.8 $18.62 5/31/2023909,800 shares $15.24 million +6.8%4.7%5.5 $16.75 5/15/2023852,000 shares $14.11 million -11.3%4.4%6.2 $16.56 4/30/2023960,800 shares $14.34 million +0.2%5.0%8.7 $14.92 4/15/2023959,400 shares $11.10 million -3.3%5.0%9.3 $11.57 3/31/2023991,600 shares $12.46 million -4.7%5.2%12 $12.57 3/15/20231,040,000 shares $14.29 million +4.3%5.4%14.2 $13.74 2/28/2023996,700 shares $15.44 million +1.1%5.4%12 $15.49 2/15/2023985,900 shares $15.12 million +1.8%5.3%11.2 $15.34 1/31/2023968,800 shares $15.27 million -6.9%5.1%9.9 $15.76 1/15/20231,040,000 shares $15.12 million No Change5.5%9.7 $14.54 12/30/20221,040,000 shares $15.25 million +19.0%6.1%10.9 $14.66 12/15/2022874,300 shares $12.91 million -28.9%5.1%9.1 $14.77 11/30/20221,230,000 shares $20.68 million -3.2%7.2%12.8 $16.81 11/15/20221,270,000 shares $22.61 million -14.8%7.4%13.7 $17.80 10/31/20221,490,000 shares $27.45 million -0.7%8.9%16.6 $18.42 10/15/20221,500,000 shares $25.47 million +0.7%9.0%17.5 $16.98 9/30/20221,490,000 shares $25.51 million +19.2%8.9%17.4 $17.12 9/15/20221,250,000 shares $19.96 million No Change7.5%11.1 $15.97 8/31/20221,250,000 shares $19.23 million No Change7.5%10.6 $15.38 8/15/20221,250,000 shares $22.99 million -1.6%7.5%8.6 $18.39 7/31/20221,270,000 shares $19.08 million -3.8%7.7%6.9 $15.02 7/15/20221,320,000 shares $19.34 million +8.2%8.0%5.6 $14.65 6/30/20221,220,000 shares $17.81 million +91.4%7.4%5.2 $14.60 6/15/2022637,400 shares $8.34 million +45.9%3.9%2.8 $13.09 5/31/2022437,000 shares $6.01 million +13.0%2.6%2.4 $13.75 5/15/2022386,800 shares $5.08 million -32.2%2.3%2.6 $13.13 4/30/2022570,200 shares $10.44 million -3.0%5.9%5.1 $18.31 4/15/2022587,800 shares $10.80 million +7.3%6.1%14 $18.38 3/31/2022548,000 shares $9.22 million +35.4%5.7%14.2 $16.82 3/15/2022404,600 shares $7.17 million +4.7%4.2%11.4 $17.71 2/28/2022386,400 shares $6.81 million +10.0%4.0%13.2 $17.63 2/15/2022351,200 shares $5.62 million +6.3%3.6%11.9 $16.00 1/31/2022330,300 shares $6.63 million +2.3%3.4%11.6 $20.07 1/15/2022322,900 shares $6.70 million -0.7%3.3%12.2 $20.75 12/31/2021325,200 shares $7.32 million 0.0%3.4%10.9 $22.50 12/15/2021325,300 shares $8.57 million +2.7%3.4%10.9 $26.34 11/30/2021316,700 shares $8.42 million +1.3%3.3%10.5 $26.60 11/15/2021312,600 shares $7.99 million -3.3%3.3%10.1 $25.56 10/29/2021323,100 shares $8.97 million -2.3%3.5%11.8 $27.76 10/15/2021330,800 shares $9.43 million +0.6%3.5%11 $28.52 9/30/2021329,000 shares $7.09 million +0.2%3.5%11.9 $21.55 9/15/2021328,400 shares $7.16 million +7.5%3.5%9.3 $21.81 8/31/2021305,400 shares $8.09 million -1.7%3.3%5.6 $26.50 8/13/2021310,800 shares $8.07 million -2.4%3.3%5.3 $25.98 7/30/2021318,500 shares $7.19 million -2.7%3.6%5 $22.57Crypto’s crashing…but we’re still profiting (Ad)Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess. The news is screaming fear. But while most traders watch their portfolios tank…my friend Joel and his team at The Crypto Code are doing the opposite. 7/15/2021327,200 shares $8.43 million +3.1%3.7%4.7 $25.76 6/30/2021317,500 shares $9.20 million +12.8%3.6%4.5 $28.98 6/15/2021281,400 shares $9.92 million -10.4%3.3%4.2 $35.26 5/28/2021314,000 shares $10.46 million -15.4%3.7%6.6 $33.32 5/14/2021371,100 shares $10.99 million -3.3%4.3%8.3 $29.62 4/30/2021383,600 shares $11.58 million +0.1%4.5%9.1 $30.20 4/15/2021383,400 shares $11.51 million -5.6%4.5%11.5 $30.01 3/31/2021406,300 shares $11.50 million +3.2%4.8%11.1 $28.30 3/15/2021393,800 shares $13.19 million +6.6%4.7%5.2 $33.50 2/26/2021369,400 shares $13.87 million +5.9%4.4%4.2 $37.56 2/12/2021348,800 shares $12.82 million +34.1%4.2%3.8 $36.76 1/29/2021260,200 shares $10.13 million +2.9%3.1%2.8 $38.92 1/15/2021253,000 shares $11.11 million No Change3.0%2.5 $43.91 TARS Short Interest - Frequently Asked Questions What is Tarsus Pharmaceuticals' current short interest? Short interest is the volume of Tarsus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 8,380,000 shares of TARS short. 23.89% of Tarsus Pharmaceuticals' shares are currently sold short. Learn More on Tarsus Pharmaceuticals' current short interest. What is a good short interest ratio for Tarsus Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TARS shares currently have a short interest ratio of 13.0. Learn More on Tarsus Pharmaceuticals's short interest ratio. Which institutional investors are shorting Tarsus Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Tarsus Pharmaceuticals: Group One Trading LLC, Citadel Advisors LLC, Jane Street Group LLC, Susquehanna International Group LLP, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Tarsus Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 23.89% of Tarsus Pharmaceuticals' floating shares are currently sold short. Is Tarsus Pharmaceuticals' short interest increasing or decreasing? Tarsus Pharmaceuticals saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 8,380,000 shares, an increase of 9.5% from the previous total of 7,650,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Tarsus Pharmaceuticals' short interest compare to its competitors? 23.89% of Tarsus Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Tarsus Pharmaceuticals: Roivant Sciences Ltd. (11.68%), Lantheus Holdings, Inc. (10.23%), Revolution Medicines, Inc. (10.62%), BridgeBio Pharma, Inc. (15.57%), Legend Biotech Co. (5.49%), TG Therapeutics, Inc. (16.90%), Blueprint Medicines Co. (9.08%), Sarepta Therapeutics, Inc. (7.51%), Axsome Therapeutics, Inc. (11.68%), Nuvalent, Inc. (14.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Tarsus Pharmaceuticals stock? Short selling TARS is an investing strategy that aims to generate trading profit from Tarsus Pharmaceuticals as its price is falling. TARS shares are trading down $0.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tarsus Pharmaceuticals? A short squeeze for Tarsus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TARS, which in turn drives the price of the stock up even further. How often is Tarsus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TARS, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Roivant Sciences Short Interest Lantheus Short Interest Revolution Medicines Short Interest BridgeBio Pharma Short Interest Legend Biotech Short Interest TG Therapeutics Short Interest Blueprint Medicines Short Interest Sarepta Therapeutics Short Interest Axsome Therapeutics Short Interest Nuvalent Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TARS) was last updated on 4/29/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tarsus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tarsus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TARS Stock Free TARS Stock Alerts